- Home
- LDWY vs BMRA Comparison
LDWY vs BMRA Comparison
Compare LDWY & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LDWY
- BMRA
- Stock Information
- Founded
- LDWY 1990
- BMRA 1971
- Country
- LDWY United States
- BMRA United States
- Employees
- LDWY N/A
- BMRA N/A
- Industry
- LDWY Advertising
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- LDWY Consumer Discretionary
- BMRA Health Care
- Exchange
- LDWY Nasdaq
- BMRA Nasdaq
- Market Cap
- LDWY 6.7M
- BMRA 7.4M
- IPO Year
- LDWY 1991
- BMRA N/A
- Fundamental
- Price
- LDWY $3.42
- BMRA $0.32
- Analyst Decision
- LDWY
- BMRA
- Analyst Count
- LDWY 0
- BMRA 0
- Target Price
- LDWY N/A
- BMRA N/A
- AVG Volume (30 Days)
- LDWY 9.9K
- BMRA 68.2K
- Earning Date
- LDWY 11-11-2024
- BMRA 10-15-2024
- Dividend Yield
- LDWY N/A
- BMRA N/A
- EPS Growth
- LDWY N/A
- BMRA N/A
- EPS
- LDWY N/A
- BMRA N/A
- Revenue
- LDWY $24,813,000.00
- BMRA $5,509,000.00
- Revenue This Year
- LDWY N/A
- BMRA N/A
- Revenue Next Year
- LDWY N/A
- BMRA N/A
- P/E Ratio
- LDWY N/A
- BMRA N/A
- Revenue Growth
- LDWY N/A
- BMRA 1.74
- 52 Week Low
- LDWY $3.02
- BMRA $0.24
- 52 Week High
- LDWY $6.88
- BMRA $2.13
- Technical
- Relative Strength Index (RSI)
- LDWY 46.04
- BMRA 47.45
- Support Level
- LDWY $3.34
- BMRA $0.28
- Resistance Level
- LDWY $3.66
- BMRA $0.35
- Average True Range (ATR)
- LDWY 0.20
- BMRA 0.03
- MACD
- LDWY 0.04
- BMRA 0.00
- Stochastic Oscillator
- LDWY 62.50
- BMRA 38.50
About LDWY Lendway Inc. (DE)
Lendway Inc is a specialty agricultural and finance company focused on making and managing its ag investments in the United States and internationally. The company operates in two Industry Specialty Ag, consisting of the Bloomia business, and Non-bank Lending, consisting of the Lending Business.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Europe market.